FGF2 and tendinitis: In one clinical study, the plasmid DNA encoding two therapeutic species‐specific growth factors VEGF164 and fibroblast growth factor 2 (FGF2), were successfully used to treat SDF tendinitis and desmitis of suspensory ligament branch.58